Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Polyps 2Hyperplasia 2Colorectal Neoplasms 2Weight Loss 1Psoriasis 1Osteoarthritis 1Colitis, Ulcerative 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Cancer Cachexia 1Cachexia 1Breast Neoplasms 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Anorexia 1Adenomatous Polyps 1Adenomatous Polyposis Coli 1

Interventions

Fluorouracil 255Leucovorin 224Oxaliplatin 218Irinotecan 206Bevacizumab 200Capecitabine 144Cetuximab 136Panitumumab 68Folfox protocol 63regorafenib 50Colonoscopy 44pembrolizumab 42IFL protocol 39Radiotherapy 32Nivolumab 31Drug Therapy 27trifluridine tipiracil drug combination 26Gemcitabine 24Blood Specimen Collection 23Chemotherapy, Adjuvant 20Surveys and Questionnaires 19Celecoxib 19Surgical Procedures, Operative 16durvalumab 15Neoadjuvant Therapy 15Cyclophosphamide 14Cisplatin 14aflibercept 13Standard of Care 13Pemetrexed 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Colorectal Neoplasms × Eicosapentaenoic Acid × Clear all
NCT01661764 2018-06-08

Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention

Vanderbilt University Medical Center

Phase 2 Completed
141 enrolled 16 charts
Gastrointestinal

Colorectal Neoplasms

NCT00168987 2008-05-09

Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors

Charite University, Berlin, Germany

Phase 4 Completed
30 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡